Statistics

Total Visits

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials69

Select a period of time:

Number of views in the range

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials48

Views

Views
January 20251
February 20251
March 202513
April 202512
May 20256
June 202515
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore34
Hong Kong10
United States3
Spain1
 

Top cities views

Views
Hong Kong10
Buffalo1
Council Bluffs1
Los Angeles1